Add-ons

ImmunoMind

Harness the power of AI and accelerate reporting in CAR-T research 

ImmunoMind, which graduated from UC Berkeley SkyDeck, helps companies and medical centres design and produce safer and more effective CAR-T and other Cell Therapies, leveraging a proprietary multi-omics database of immune cells and AI. This collaboration connects eLabNext users to the ImmunoMind platform and enhances reporting in eLabJournal by using results from multi-omics driven drug development and manufacturing.

The ImmunoMind add-on identifies both cell subpopulations (e.g. Tscm, Tcm, Tem, Treg, NK, gdT cells) as well as their characteristics (e.g. exhaustion, senescence, activation) to create a comprehensive profile of CAR-T and other Cell Therapy products.

  • The profile can help select the most effective design and dosage for CAR-T, improve QC and SOP to select T-cell subsets (such as Tscm and T-cell precursors), assess exhaustion and persistence of CAR-T cells in vitro and in vivo, and more.
  • The platform supports Go/No-Go decision-making and reduces the risk of immunotherapy development and manufacturing.

Bring forth the synergy between biologists, medical scientists, data scientists and bioinformaticians. 

Understanding the extensive cell heterogeneity leads to safer CAR-T therapies 

ImmunoMind UI

Transcriptomics driven selection of CAR-T candidates

ImmunoMind UI

Targeting the T-cell exhaustion to improve the efficacy of CAR-T therapy

ImmunoMind UI

Improving clinical trials with bulk RNA-sequencing

ImmunoMind UI

 

The ImmunoMind add-on is available free of charge in the eLab Marketplace.

Learn more about ImmunoMind

 

< Back to overview

Get Your All-in-One Digital Lab Management Tools Today!

Personal demo, free lab workflow assessment, and friendly expert guidance.